These tumors only respond to high doses of chemotherapy and acquire resistance rapidly, as evidenced by the low salvage rates of only 20% in patients with relapsing disease.42 Our results suggest the AKT-SOX2 axis as a potential key regulator of cancer cell populations that are prone to survive platinum exposure, enriched with antioxidant response mechanisms. This evidence concerns the gene SOX2 and cancer.